NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions

The introduction of non-vitamin K antagonists oral anticoagulants, a class of medicines which includes dabigatran, apixaban, edoxaban and rivaroxaban, has resulted in improvements in the safety and efficacy of non valvular atrial fibrillation treatment for stroke prevention, with significant reducti...

Full description

Bibliographic Details
Main Authors: Mariachiara Di Cesare, Jordan D. Jarvis, Oana Scarlatescu, Xinyi Leng, Ezequiel J. Zaidel, Esteban Burrone, Jean-Luc Eiselé, Dorairaj Prabhakaran, Karen Sliwa
Format: Article
Language:English
Published: Ubiquity Press 2020-10-01
Series:Global Heart
Subjects:
Online Access:https://globalheartjournal.com/articles/774